Alcidion Group Limited · ASX:ALC

Alcidion — Shareholder Meeting (November 2022)

15 slides from Alcidion's shareholder meeting presentation, Nov 30, 2022

  1. Slide 1: Group Managing Director Report

    For personal use only Group Managing Director Report Kate Quirke Group Managing Director | CEO

  2. Slide 2: Market outlook

    Market outlook For personal use only Hospitals are increasingly seeking seamless, digital solutions to manage clinical workflow Transition to digital Increasing industry Increasing demand Increasing market support & funding for seamless clinical interest & activity solutions Shift towards digital wi

  3. Slide 3: Digital strategy provides potential to disrupt large EPR vendors

    Digital strategy provides potential to disrupt large EPR vendors For personal use only NHS + digital health market changing in UK, leading to growing adoption of larger integrated EPR contracts • Concept of an EPR is maturing in the UK; market moving from standalone PAS to an integrated EPR given in

  4. Slide 4: Alcidion's flow solution: Miya Flow

    Alcidion’s flow solution: Miya Flow For personal use only • Foundation module of Miya Precision, Miya Flow addresses these challenges by • Providing clinicians with insight to all factors relevant to managing care of patient across entire stay • Real-time consolidated information • Efficient handove

  5. Slide 5: Virtual Care: overview & positioning

    For personal use only Virtual Care: overview & positioning 5

  6. Slide 6: What is Virtual Care?

    6 What is Virtual Care? For personal use only • Long been recognised that patients recuperate better at home than in hospital o Also helps contain healthcare costs • COVID accelerated digitally-enabled methods of care, demonstrating tech facilitates safer patient outcomes • Virtual Care uses digital

  7. Slide 7: Alcidion at the forefront of Virtual Care delivery

    7 Alcidion at the forefront of Virtual Care delivery… For personal use only • Alcidion originally developed Virtual Care for monitoring of COVID patients o Focused on visualisations so information was immediately meaningful to clinicians o Critical was our integration capability to source relevant d

  8. Slide 8: Case Study: Virtual Care at Sydney LHD

    Case Study: Virtual Care at Sydney LHD For personal use only “ rpaVirtual has now delivered virtual care safely with great results to over 63,000 patients. Alcidion’s Miya Platform provides our clinicians the tools they need to deliver great quality care virtually, with the best possible outcomes fo

  9. Slide 9: Virtual Care in action: product demonstration

    For personal use only Virtual Care in action: product demonstration Commercial in Confidence

  10. Slide 10: Outlook

    Outlook For personal use only Key Comments • Ending FY23 Q1 with strong contracted revenue of $29.0M to be recognised in FY23, 69% higher than at same time last year • Further $2.6M of scheduled renewal, expected to be converted to contracted revenue over FY23 • Very confident in pipeline of opportu

  11. Slide 11: Risk management update

    For personal use only Risk management update Commercial in Confidence

  12. Slide 12: Additional information with regard to Risk Management and Key Risks

    Additional information with regard to Risk Management and Key Risks For personal use only There are various internal and external risks that may have a material impact on the Group’s future financial performance and economic sustainability. The Group makes every effort to identify material risks and

  13. Slide 13: Additional information with regard to Risk Management and Key Risks (cont.)

    Additional information with regard to Risk Management and Key Risks (cont.) For personal use only Cyber security threat from Data breach, Targeted data theft and/or Operational disruption including Statutory Liability arising from Privacy and Data Breaches A cyber security breach has the potential t

  14. Slide 14: Disclaimer

    14 Disclaimer For personal use only The information contained in this document (“Document”) has been prepared by Alcidion Group Limited ACN 143 142 410 (referred to as “Alcidion” or “Company”). This Document is current as at the date of this Document and should be read in conjunction with other Alci

  15. Slide 15: For personal use only

    For personal use only

Alcidion Group — Shareholder Meeting (November 2022) on 6ix